Medicare Advantage
2024 Pharmacy Star Measurement Changes
March 7, 2024
For the 2024 measurement year, there are two calculation changes to the statin use in persons with diabetes (SUPD) measure.
- The Centers for Medicare & Medicaid Services (CMS) no longer adjusts for member years and instead now uses continuous enrollment (CE). The CE treatment period now excludes members with a gap of more than one day in their enrollment. For providers and health plans, this means each member now counts as a “one” versus the old method which calculated based on the amount of time in the measure. This shouldn’t have a significant impact to your percentage and Star Rating, but is part of the changes that CMS made that can impact a provider score. This measure aligns with the current Pharmacy Quality Alliance measure specification.
-
The eligible age for the SUPD measure for individuals aged 40 to 75 changed on January 1, 2024. Any individual aged 75 during the measurement period (regardless if they turn 76 that year) will now be counted for the full year if they meet all other eligibility criteria. We request that you review and continue to prescribe a statin for all diabetic patients aged 40 through 75 at the beginning and through the entire measurement year.